Anika Therapeutics, Inc. (ANIK) Insider Trading Activity

NASDAQ$20.42+0.97 (4.99%)
Market Cap
$260.3M
Sector
Healthcare
Industry
Medical—Specialties
Rank in Sector
213 of 849
Rank in Industry
5 of 13

ANIK Insider Trading Activity

ANIK Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$264,260
4
100
Sells
$0
0
0

Related Transactions

Griffin Stephen D.President and CEO
1
$149,881
0
$0
$149,881
HENNEMAN JOHN B IIIdirector
1
$73,320
0
$0
$73,320
Fischetti Gary Pdirector
2
$41,060
0
$0
$41,060

About Anika Therapeutics, Inc.

Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologies. All of Anika's products are developed, manufactured, and commercialized utilizing their proprietary hyaluronic acid (HA) technology platform. Their comprehensive product lines feature an OA pain …

Insider Activity of Anika Therapeutics, Inc.

Over the last 12 months, insiders at Anika Therapeutics, Inc. have bought $264,260 and sold $0 worth of Anika Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Anika Therapeutics, Inc. have bought $291,258 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Griffin Stephen D. (President and CEO) — $149,881. HENNEMAN JOHN B III (director) — $73,320. Fischetti Gary P (director) — $41,060.

The last purchase of 1,000 shares for transaction amount of $20,315 was made by Fischetti Gary P (director) on 2026‑08‑04.

List of Insider Buy and Sell Transactions, Anika Therapeutics, Inc.

2026-08-04PurchaseFischetti Gary Pdirector
1,000
0.0077%
$20.32
$20,315
+6.40%
2026-08-03PurchaseFischetti Gary Pdirector
1,000
0.0074%
$20.75
$20,745
+0.58%
2026-05-01PurchaseHENNEMAN JOHN B IIIdirector
5,000
0.0368%
$14.66
$73,320
+29.36%
2026-04-30PurchaseGriffin Stephen D.President and CEO
12,200
0.0839%
$12.29
$149,881
+54.14%
2022-05-11PurchaseColleran DavidEVP, General Counsel, Corp Sec
1,500
0.0104%
$21.37
$32,055
+22.64%
2022-03-14PurchaseColleran DavidEVP, General Counsel, Corp Sec
1,500
0.0109%
$26.65
$39,978
-3.85%
2022-03-11PurchaseBlanchard Cheryl RPresident, CEO, Director
3,813
0.0266%
$25.81
$98,429
-4.61%
2022-03-11PurchaseThompson Jeffery S
2,000
0.0133%
$24.66
$49,318
-4.61%
2022-03-11PurchaseLevitz Michael LEVP, CFO, Treasurer
4,000
0.0266%
$24.62
$98,476
-4.61%
2021-08-12PurchaseLevitz Michael LEVP, CFO, Treasurer
777
0.0053%
$40.20
$31,239
-23.48%
2021-08-11PurchaseLevitz Michael LEVP, CFO, Treasurer
2,850
0.0196%
$40.21
$114,587
-22.71%
2021-05-18PurchaseHENNEMAN JOHN B IIIdirector
2,000
0.014%
$42.86
$85,720
-6.92%
2021-05-12SaleLAND RAYMOND Jdirector
2,000
0.014%
$42.60
$85,200
-5.92%
2020-11-10SaleLAND RAYMOND Jdirector
3,446
0.0232%
$36.77
$126,709
+6.14%
2020-07-09SaleLoerop JamesEVP Business Development
1,244
0.0089%
$35.15
$43,727
+8.80%
2020-02-26SaleLAND RAYMOND Jdirector
2,700
0.0192%
$42.68
$115,236
-13.87%
2019-11-08SaleCheung SylviaChief Financial Officer
20,000
0.1389%
$59.71
$1.19M
-39.44%
2019-08-28SaleLarsen Glenn R.director
4,355
0.031%
$57.21
$249,150
-27.63%
2019-08-20SaleBower Joseph L.director
1,994
0.0141%
$55.57
$110,807
-24.80%
2019-08-08SaleThompson Jeffery Sdirector
4,843
0.0345%
$56.66
$274,404
-24.77%
Total: 126
*Gray background shows transactions not older than one year

Insider Historical Profitability

2.26%
HENNEMAN JOHN B IIIdirector
54871
0.41%
$1.07M20
<0.0001%
Fischetti Gary Pdirector
54015
0.4036%
$1.05M20
Griffin Stephen D.President and CEO
36163
0.2702%
$703,370.3510
Blanchard Cheryl RPresident, CEO, Director
59992
0.4483%
$1.17M10
<0.0001%
QUINLAN KEVIN WChief Financial Officer
27112
0.2026%
$527,328.4052
+3.86%
Darling Joseph GPresident and CEO; Director
22436
0.1676%
$436,380.2010
+38.89%
Thompson Jeffery S
17121
0.1279%
$333,003.4514
<0.0001%
Levitz Michael LEVP, CFO, Treasurer
15924
0.119%
$309,721.8030
<0.0001%
Colleran DavidEVP, General Counsel, Corp Sec
9867
0.0737%
$191,913.1520
+9.4%
Mrachek WilliamVice President, Human Resource
6854
0.0512%
$133,310.3020
+13.04%
*Gray background shows insiders who have made transactions during last year

ANIK Institutional Investors: Active Positions

Increased Positions78+70.91%2M+18.15%
Decreased Positions47-42.73%2M-16.55%
New Positions24New444,979New
Sold Out Positions13Sold Out81,276Sold Out
Total Postitions141+28.18%12M+1.6%

ANIK Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$16,285.0012.44%1.74M+213,476+13.97%2025-09-30
Trigran Investments, Inc.$15,158.0011.58%1.62M-415,296-20.39%2025-09-30
Caligan Partners Lp$13,418.0010.25%1.44M00%2025-09-30
Vanguard Group Inc$7,299.005.58%780,663+1,190+0.15%2025-09-30
Acadian Asset Management Llc$5,917.004.52%632,791+57,147+9.93%2025-09-30
Dimensional Fund Advisors Lp$5,621.004.29%601,163-21,921-3.52%2025-09-30
Capital Management Corp /Va$5,154.003.94%551,248+142,403+34.83%2025-09-30
Boothbay Fund Management, Llc$5,046.003.86%539,642+10,139+1.92%2025-09-30
Renaissance Technologies Llc$4,984.003.81%533,017+5,800+1.1%2025-09-30
Morgan Stanley$3,691.002.82%394,741+286,359+264.21%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.